Health-care companies rose amid deal activity.

Health-care conglomerate Johnson & Johnson has struck a $13.1 billion deal to buy Shockwave Medical, strengthening its hand in the cardiovascular field.

Swiss drug giant Novartis's latest data on its Pluvicto prostate-cancer therapy clears a path to seek regulatory approval for an expanded label, said analysts at brokerage UBS.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

04-05-24 1743ET